Literature DB >> 2886341

Airway response to salbutamol and to ipratropium bromide after non-selective and cardioselective beta-blocker.

P Desche, A Cournot, J Duchier, J F Prost.   

Abstract

Eight healthy men were randomly assigned in a latin square order to receive single doses of placebo, tertatolol 5 mg, propranolol 80 mg and atenolol 100 mg at 7-day intervals. Resting heart rate and pulmonary function were measured 10 min before and over the 240 min following dosing, and then 15 min after inhalation of salbutamol 200 micrograms and ipratropium bromide 40 micrograms. The three beta-blockers caused similar reductions in resting heart rate throughout the study, whereas placebo had no effect. The three beta-blockers, like placebo, produced no significant change in pulmonary function during the 240 min after dosing. The bronchodilator response to salbutamol after atenolol and placebo was preserved, whereas it was reduced after administration of either of the non-selective beta-blockers, tertatolol and propranolol. An unequivocal response of the airways to ipratropium bromide was observed after tertatolol and propranolol, which was much greater than after atenolol. No response was observed after placebo. Thus, despite bronchial beta 2-blockade, by non-selective beta-blockers, bronchodilatation was definitely produced by ipratropium bromide, confirming the predominant role of the parasympathetic system in the autonomic innervation of normal human airways.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886341     DOI: 10.1007/bf00543966

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma.

Authors:  B N Singh; R M Whitlock; R H Comber; F H Williams; E A Harris
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects.

Authors:  P J Barnes; N B Pride
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

3.  Role of the parasympathetic system in airway obstruction due to emphysema.

Authors:  N J Gross; M S Skorodin
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

4.  Bronchodilator drugs.

Authors:  J W Paterson; A J Woolcock; G M Shenfield
Journal:  Am Rev Respir Dis       Date:  1979-11

5.  Quantitative determination of tertatolol in biological fluids by gas chromatography-mass spectrometry.

Authors:  S Staveris; P Blaise; C Efthymiopoulos; M Schneider; G Jamet; L Jung; J C Koffel
Journal:  J Chromatogr       Date:  1985-04-12

6.  Reduction of beta-adrenergic receptors by tertatolol: an additional mechanism for beta-adrenergic blockade.

Authors:  A De Blasi; M Lipartiti; F Pirone; C Rochat; J F Prost; S Garattini
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

7.  Assessment of beta-adrenoceptor antagonists in asthmatic patients.

Authors:  R E Ruffin; E L McIntyre; K M Latimer; H E Ward; A J Crockett; J H Alpers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Effect of penbutolol and propranolol on normal airway response to salbutamol.

Authors:  J B Warren; A T Monaghan; T J Clark
Journal:  Clin Pharmacol Ther       Date:  1984-07       Impact factor: 6.875

9.  Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma.

Authors:  P G Wilcox; D Ahmad; A C Darke; J Parsons; S G Carruthers
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

Review 10.  Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

View more
  2 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.